RWA Wealth Partners LLC Boosts Stock Position in Danaher Corporation $DHR

RWA Wealth Partners LLC boosted its position in shares of Danaher Corporation (NYSE:DHR) by 1,155.1% during the second quarter, Holdings Channel.com reports. The firm owned 80,891 shares of the conglomerate’s stock after buying an additional 74,446 shares during the quarter. RWA Wealth Partners LLC’s holdings in Danaher were worth $15,979,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. MGO One Seven LLC grew its holdings in Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after acquiring an additional 20,813 shares in the last quarter. Chicago Capital LLC lifted its position in Danaher by 11.6% in the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock valued at $2,634,000 after purchasing an additional 1,391 shares during the period. UniSuper Management Pty Ltd grew its position in Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after buying an additional 2,667 shares during the period. Asahi Life Asset Management CO. LTD. purchased a new position in shares of Danaher in the first quarter valued at $539,000. Finally, ASR Vermogensbeheer N.V. raised its holdings in shares of Danaher by 1.9% in the second quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock worth $63,787,000 after acquiring an additional 6,136 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 11.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have commented on DHR. Rothschild & Co Redburn restated a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Guggenheim reissued a “buy” rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Redburn Partners set a $220.00 price objective on Danaher in a report on Wednesday, October 8th. Finally, Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Stock Down 0.4%

NYSE DHR opened at $209.89 on Friday. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The firm has a market cap of $148.26 billion, a PE ratio of 43.28, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The stock’s 50 day simple moving average is $204.02 and its 200 day simple moving average is $200.32.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.